Table 1 Patient’s characteristics
Characteristic | Value |
|---|---|
Age (years) | |
Mean ± SD (range)—years | 40.7 ± 15.96 (12–92) |
Gender—no. (%) | |
Male | 72 (48) |
Female | 77 (52) |
Severity of pain—no. (%) | |
Mild | 33 (22) |
Moderate | 116 (78) |
Duration of pain—no. (%) | |
Acute | 100 (67) |
Sub-acute | 37 (25) |
Chronic | 12 (8) |
Co-morbid diseases—no. (%) | |
Hypertension | 45 (30) |
CAD | 23 (15) |
Diabetes | 12 (8) |
PUD | 12 (8) |
Concomitant medications with NSAIDs—no. (%) | |
Anti-hypertensives | 49 (33) |
PPIs | 34 (23) |
Anti-lipidemics | 24 (16) |
Anti-diabetics | 13 (9) |
Concomitant analgesics with NSAIDs—no. (%) | |
Muscle relaxant | 20 (13.5) |
Topical group | 7 (35) |
Systemic group | 11(55) |
Combination group | 2 (10) |
Acetaminophen | 12 (12.5) |
Topical group | 9 (75) |
Systemic group | 1 (9) |
Combination group | 2 (16) |
Vitamin B complex | 7 (5) |
Topical group | 0 (0) |
Systemic group | 2 (29) |
Combination group | 5 (71) |
Sites of pain—no. (%) | |
Back | 42 (28) |
Shoulder | 27 (18) |
Multiple sites* | 21 (14) |
Legs | 15 (10) |
Neck | 13 (9) |
Ankle | 12 (8) |
Hands | 6 (4) |
Knees | 6 (4) |
Fingers | 4 (3) |
Elbow | 3 (2) |
Used NSAIDs agents—no. (%) | |
Diclofenac | 76 (51) |
Ketoprofen | 45 (30) |
Aceclofenac | 37 (25) |
Naproxen | 18 (12) |
Piroxicam | 4 (2) |
Etoricoxib | 1 (0.5) |